Fig. 2From: Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinomaCorrelation between the 21-gene signature and Overall survival in the training set (early-stage LUAD). a Kaplan–Meier survival curves between high- and low-risk groups, b ROC curves for 1-year, 3-year and 5-year survival prediction by the 21-gene signatureBack to article page